Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Hangzhou Tigermed Consulting H is a leading Contract Research Organization (CRO) headquartered in China. The company provides comprehensive services for clinical research and development across pharmaceuticals, biotechnology, and medical devices. It assists global clients with the planning and execution of clinical trials, alongside regulatory consulting, to accelerate drug development.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Hangzhou Tigermed Consulting H is scheduled to report its next quarterly earnings on 08/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Hangzhou Tigermed Consulting H last reported quarterly earnings on 4/28/2026 (Q1 2026). Earnings per share (EPS) came in at 0.07 HKD.
Across its last 3 earnings reports, Hangzhou Tigermed Consulting H stock moved by ±1.8% on average the following day. The largest reaction was +3.8% on 04/28/2026; 1 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.